466 related articles for article (PubMed ID: 25877553)
1. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.
Li W; Ye L; Carrion R; Mohan GS; Nunneley J; Staples H; Ticer A; Patterson JL; Compans RW; Yang C
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S398-403. PubMed ID: 25877553
[TBL] [Abstract][Full Text] [Related]
2. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.
Mohan GS; Li W; Ye L; Compans RW; Yang C
PLoS Pathog; 2012; 8(12):e1003065. PubMed ID: 23271969
[TBL] [Abstract][Full Text] [Related]
3. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
4. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
[TBL] [Abstract][Full Text] [Related]
5. Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G; Wu H; Compans RW; Yang C
J Infect Dis; 2018 Nov; 218(suppl_5):S545-S552. PubMed ID: 29893888
[TBL] [Abstract][Full Text] [Related]
6. Protection against lethal challenge by Ebola virus-like particles produced in insect cells.
Sun Y; Carrion R; Ye L; Wen Z; Ro YT; Brasky K; Ticer AE; Schwegler EE; Patterson JL; Compans RW; Yang C
Virology; 2009 Jan; 383(1):12-21. PubMed ID: 18986663
[TBL] [Abstract][Full Text] [Related]
7. Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.
Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G; Wu H; Compans RW; Yang C
Sci Rep; 2018 Jul; 8(1):11193. PubMed ID: 30046140
[TBL] [Abstract][Full Text] [Related]
8. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.
Pallesen J; Murin CD; de Val N; Cottrell CA; Hastie KM; Turner HL; Fusco ML; Flyak AI; Zeitlin L; Crowe JE; Andersen KG; Saphire EO; Ward AB
Nat Microbiol; 2016 Aug; 1(9):16128. PubMed ID: 27562261
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
10. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS
PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247
[TBL] [Abstract][Full Text] [Related]
11. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
12. A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice.
Chen T; Li D; Song Y; Yang X; Liu Q; Jin X; Zhou D; Huang Z
Antiviral Res; 2017 Sep; 145():54-59. PubMed ID: 28733113
[TBL] [Abstract][Full Text] [Related]
13. Immunization for Ebola virus infection.
Xu L; Sanchez A; Yang Z; Zaki SR; Nabel EG; Nichol ST; Nabel GJ
Nat Med; 1998 Jan; 4(1):37-42. PubMed ID: 9427604
[TBL] [Abstract][Full Text] [Related]
14. Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates.
Marcus H; Thompson E; Zhou Y; Bailey M; Donaldson MM; Stanley DA; Asiedu C; Foulds KE; Roederer M; Moliva JI; Sullivan NJ
Front Immunol; 2021; 12():627688. PubMed ID: 33790899
[TBL] [Abstract][Full Text] [Related]
15. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
16. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
[TBL] [Abstract][Full Text] [Related]
18. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
19. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice.
Mitchell DAJ; Dupuy LC; Sanchez-Lockhart M; Palacios G; Back JW; Shimanovskaya K; Chaudhury S; Ripoll DR; Wallqvist A; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2883-2893. PubMed ID: 28699812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
